García-Ríos Estéfani, Rodríguez María Josefa, Terrón María Carmen, Luque Daniel, Pérez-Romero Pilar
National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Department of Science, Universidad Internacional de Valencia-VIU, Pintor Sorolla 21, 46002 Valencia, Spain.
Vaccines (Basel). 2022 Aug 12;10(8):1308. doi: 10.3390/vaccines10081308.
Dense bodies (DB) are complex, noninfectious particles produced during CMVinfection containing envelope and tegument proteins that may be ideal candidates as vaccines. Although DB were previously described in fibroblasts, no evidence of DB formation has been shown after propagating CMV in epithelial cells. In the present study, both fibroblast MRC-5 and epithelial ARPE-19 cells were used to study DB production during CMV infection. We demonstrate the formation of epithelial cell-derived DB, mostly located as cytoplasmic inclusions in the perinuclear area of the infected cell. DB were gradient-purified, and the nature of the viral particles was confirmed using CMV-specific immunelabeling. Epithelial cell-derived DB had higher density and more homogeneous size (200-300 nm) compared to fibroblast-derived DB (100-600 nm).In agreement with previous results characterizing DB from CMV-infected fibroblasts, the pp65 tegument protein was predominant in the epithelial cell-derived DB. Our results also suggest that epithelial cells had more CMV capsids in the cytoplasm and had spherical bodies compatible with nucleus condensation (pyknosis) in cells undergoing apoptosis that were not detected in MRC-5 infected cells at the tested time post-infection. Our results demonstrate the formation of DB in CMV-infected ARPE-19 epithelial cells that may be suitable candidate to develop a multiprotein vaccine with antigenic properties similar to that of the virions while not including the viral genome.
致密体(DB)是巨细胞病毒(CMV)感染期间产生的复杂的、非感染性颗粒,含有包膜和衣壳蛋白,可能是理想的疫苗候选物。尽管之前在成纤维细胞中描述过致密体,但在CMV在上皮细胞中增殖后,尚未有致密体形成的证据。在本研究中,成纤维细胞MRC-5和上皮细胞ARPE-19均被用于研究CMV感染期间致密体的产生。我们证明了上皮细胞来源的致密体的形成,其大多作为胞质内含物位于感染细胞的核周区域。致密体经过梯度纯化,利用CMV特异性免疫标记确认了病毒颗粒的性质。与成纤维细胞来源的致密体(100-600nm)相比,上皮细胞来源的致密体密度更高,大小更均匀(200-300nm)。与之前对CMV感染的成纤维细胞中致密体的表征结果一致,pp65衣壳蛋白在上皮细胞来源的致密体中占主导。我们的结果还表明,上皮细胞在胞质中有更多的CMV衣壳,并且在感染后测试时间点的凋亡细胞中有与核固缩(核致密)相符的球体,而在MRC-5感染细胞中未检测到。我们的结果证明了在CMV感染的ARPE-19上皮细胞中致密体的形成,其可能是开发具有与病毒体相似抗原特性但不包含病毒基因组的多蛋白疫苗的合适候选物。